"In the highly specific field of rare diseases, it is particularly important to develop not only innovative but above all effective drugs and reliable treatments. We have the highest quality standards, as we know that our products are vital for patients. Quality begins by placing customer satisfaction at the center of our thinking."
Personal Data Sheet
Christoph Reinwald has a Master of Science in Biotechnological Quality Management as well as a post-graduate degree as a Pharmaceutical Qualified Person from the University of Vienna. He has years of experience working in the pharmaceutical industry. Previously, Reinwald served as co-CEO of OrphaCare GmbH, as well as Head of Quality Assurance & Pharmacovigilance at Amomed Pharma GmbH, which was integrated into the AOP Health group. As Chief Technology Officer at AOP Health, Mr. Reinwald is responsible for Supply Chain Management, Production & Manufacturing as well as Quality Management.